Epigral Ltd to Hold Board Meeting on May 2 for FY Results and Dividend Recommendation
Epigral Ltd announced that its Board of Directors is scheduled to meet on Saturday, May 2, 2026, at the company’s Registered Office. The meeting is set to consider and approve the financial results for the Fourth Quarter and the full Financial Year ended March 31, 2026, along with reviewing the potential recommendation of a final dividend.The Board meeting agenda is focused on two primary corporate matters concerning the company's performance during the fiscal year.
The key objectives for the Board meeting include:
- Financial Results Approval: Consideration and approval of the Audited Financial Results (both Standalone and Consolidated) for the Fourth Quarter and the full year ending March 31, 2026. This session will also include taking on record the report provided by the Statutory Auditors.
- Dividend Recommendation: Assessing and recommending a Final Dividend, if any, on the company's Equity Shares, which have a face value of Rs. 10/- each, for the Financial Year ending March 31, 2026.
EPIGRAL Stock Price Movement
Shares of Epigral Limited are gaining momentum, currently trading at ₹1213.15 as of 12:30 PM, following a strong jump of ₹10.30. The stock is navigating a solid trading day, which has seen it move within a range of ₹1190.35 to ₹1228.65 amid 32,510 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.